Theravance Biopharma (TBPH) Finished Goods (2013 - 2018)
Theravance Biopharma (TBPH) posted Finished Goods of $3.51 million for Q3 2018, down 22.9% from $4.55 million a year earlier and down 11.8% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Finished Goods (2013 - 2018) Analysis & Trends
At the end of FY2017, Theravance Biopharma's Finished Goods came in at $5.04 million, up 42.8% from FY2016.
- Annual Finished Goods shows a four-year compound annual growth rate of 0.6% (FY2013 to FY2017).
- In prior years, Theravance Biopharma's Finished Goods was $3.53 million in FY2016 (+12.4%), $3.14 million in FY2015 (-43.7%), $5.57 million in FY2014 (+13.5%) and $4.91 million in FY2013.
- The Q3 2018 figure stands as the lowest quarterly Finished Goods since Q2 2017.
- On a year-over-year basis, Finished Goods increased in six of the last eight quarters, with growth averaging 26.0%.
- The strongest year-over-year quarter for Finished Goods in the past five years was Q2 2018, with growth of 99.6%; the weakest was Q2 2016, with a decline of 58.8%.
- According to Business Quant data, Finished Goods for the three prior quarters was $3.98 million (Q2 2018), $4.62 million (Q1 2018) and $5.04 million (Q4 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.34 Bn | 1,100.93 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.91 Bn | 534.44 Bn | 17.26 Bn |
| 3 | AbbVie | 505.47 Bn | 478.59 Bn | 12.70 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.18 Bn | 262.17 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 236.22 Bn | 191.62 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn |
| 9 | Pfizer | 170.14 Bn | 116.79 Bn | 10.94 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 3.51 Mn |
| Jun 30, 2018 | 3.98 Mn |
| Mar 31, 2018 | 4.62 Mn |
| Dec 31, 2017 | 5.04 Mn |
| Sep 30, 2017 | 4.55 Mn |
| Jun 30, 2017 | 1.99 Mn |
| Mar 31, 2017 | 3.14 Mn |
| Dec 31, 2016 | 3.53 Mn |
| Sep 30, 2016 | 4.35 Mn |
| Jun 30, 2016 | 2.16 Mn |
| Mar 31, 2016 | 2.38 Mn |
| Dec 31, 2015 | 3.14 Mn |
| Sep 30, 2015 | 4.83 Mn |
| Jun 30, 2015 | 5.24 Mn |
| Mar 31, 2015 | 5.59 Mn |
| Dec 31, 2014 | 5.57 Mn |
| Sep 30, 2014 | 7.49 Mn |
| Jun 30, 2014 | 5.61 Mn |
| Mar 31, 2014 | 4.79 Mn |
| Dec 31, 2013 | 4.91 Mn |
API Access
Theravance Biopharma Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();